Stoke Therapeutics Inc (STU:0GT)
€ 11 0 (0%) Market Cap: 579.33 Mil Enterprise Value: 320.90 Mil PE Ratio: 0 PB Ratio: 2.60 GF Score: 36/100

Stoke Therapeutics Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2024 / 11:45PM GMT
Release Date Price: €4.76 (-1.24%)
Unidentified Participant

I mean, it was now I'm here for Jess because she's stuck trying to get out of Grand Ballroom fire hazard. And with us, we have on at our case, are the CYO. for stoke here to present on, please.

Edward Kaye Stoke Therapeutics Inc;Chief Executive Officer

Thank you, Rocco, and good afternoon, everyone. And I hope everyone is surviving the third days of JPM and have a lot of energy left on. So I'm Edward K and I'm the CEO, so therapeutics and I will be making some forward-looking statements. So please refer to our SEC documents for further description what I want to talk to today really about is our program and Dr. A., this is what a drug a child looks like at birth. And for those of you lucky enough to have children. You remember that day as a newborn, and you're just very happy that they're healthy and they and they're happy. This is what Dr. a patient looks like six to nine months later. Unfortunately, this is a genetic disease that affects about one and 16,000 children and it occurs spontaneously. So you don't know that it runs in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot